Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05379972
Title Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancers
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Colorado, Denver
Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST